基于(关键地区、市场参与者、规模和份额)的制药连续制造市场 - 到 2031 年的预测

  • Report Code : TIPRE00008245
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 239
Buy Now

药品连续制造市场预计将从 2019 年的 14.5953 亿美元增至 2027 年的 30.6438 亿美元。预计 2020 年至 2027 年该市场将以 9.8% 的复合年增长率增长。

制药行业的连续制造是生产技术方面技术进步的结果。过去几年,制药行业沿用传统的批量生产方法。然而,技术的发展加速了大规模生产,提高了质量,并解决了药品召回等许多根本性问题。制药行业最近开始承认连续制造是改善和维持制造运营的一种选择。

制药连续制造市场的利润丰厚的区域


市场洞察

药品短缺加剧

全球范围内基本药物和药品的短缺现象日益频繁。日益严重的短缺给卫生系统带来了负担,并带来了额外的费用以及患者的风险。健康。由于缺乏药物,需要药物的患者无法获得适当的剂量。根据 2016 年世界卫生组织药品信息,低收入、中等收入和高收入国家均报告基本药物短缺。由于不治疗、治疗不足以及尝试替代缺失药物可能出现的用药错误,药品短缺给患者健康带来风险。

美国食品和药物管理局 ( FDA)指出,药品短缺的原因有多种,包括质量问题、生产效率低下、延误和停产。供应经常短缺的药物包括无菌注射剂和肿瘤/癌症治疗药物。制造商向 FDA 发出的关于即将或当前的药物短缺的通知使 FDA 能够与制造商合作寻找可行的解决方案,其中之一通常是通过实施新的先进系统(例如连续制造)来增加药物的制造

2018年,美国FDA成立了新的药品短缺工作组,以探究药品短缺的原因和原因。工作组分析了2013年至2017年供应短缺的163种药物。此外,安全用药实践研究所(ISMP)2017年的一项调查显示,治疗类别最常涉及药物短缺。

药品短缺的情况在欧洲国家也普遍存在。例如,根据经济学人智库2017年发布的一份报告,欧洲药品短缺的发生率很高。确定的短缺的三个主要原因包括制造业、经济和监管原因。因此,为了满足对生物制品和药物不断增长的需求并遏制药物供应不足,药品连续制造市场拥有广阔的增长前景。

Product-BasedInsights< /h3>

2019年,集成系统领域占据全球制药连续制造市场最大的市场份额。集成系统由于其易于可用性和可访问性以及比半连续系统和控制装置更广泛的采用,预计将在产品领域占据主导地位。集成系统有助于在制造过程中建立连续流程,促进端到端集成并提高资产利用率。

全球制药连续制造市场(按产品) 2019年& 2027


基于应用的见解

根据应用,对制药连续制造市场进行细分进入最终产品制造和 API 制造。 2019 年,最终产品制造领域占据了较大的市场份额。然而,预计原料药制造领域在预测期内的市场复合年增长率更高。制药公司数量的增加、连续制造系统的技术进步和增长药品需求的增长是最终产品制造市场增长的关键驱动力。

基于最终用户的见解

基于最终用户,药品连续制造市场分为全规模制造公司和研发部门。 2019 年,大型制造公司细分市场占据了更大的市场份额。此外,预计同一细分市场在预测期内的市场复合年增长率更高。这是由于越来越多地采用连续技术来应对相关挑战产品质量、药品供应和运营成本。

战略见解

合作和收购是公司在全球范围内扩大业务并满足不断增长的需求时最常采用的策略。市场参与者最常采用这些策略来扩大其产品组合。

例如,2019 年 5 月,赛默飞世尔科技 (Thermo Fisher Scientific) 从葛兰素史克 (GlaxoSmithKline) 收购了位于爱尔兰科克的一个原料药生产基地,以满足客户对复杂活性药物成分 (API) 的开发和商业制造的需求。

全球制药连续制造市场 –副产品

  • 集成系统
  • 半连续系统
    • 连续制粒机
    • 连续搅拌机
    • 连续压缩机â欧元
    • 连续涂布机
    • 连续干燥机
    • 其他半连续系统
  • 控制
  • li>


    全球制药连续制造市场 –按应用分类

    • 最终产品制造
      • 固体制剂制造
      • 液体制剂制造
    • API制造业


    全球制药连续制造市场 –按最终用户划分

    • 大型制造公司
      • 制药公司
      • 合同制造组织
    • 研发部门
      • 合同研究组织
      • 研究机构


    制药连续制造市场–按地理位置

    • 北美洲
      • 美国
      • 加拿大
      • 墨西哥
    • < li>欧洲
      • 法国
      • 德国
      • 意大利
      • 英国
      • 西班牙
    • 亚太地区
      • 中国
      • 印度
      • 韩国
      • 日本
      • 澳大利亚< /li>
    • 中东和非洲
      • 南非
      • 沙特阿拉伯
      • 阿联酋
    • 南美洲和中美洲
      • 巴西
      • 阿根廷

     

  • p>

    公司简介

    • GEA 集团
    • Thermo Fisher Scientific, Inc.
    • Glatt GmbH
    • Munson Machinery有限公司
    • Hosokawa Micron Group
    • Coperion GmbH
    • Gericke AG
    • Powerex Corp
    • Freund -Vector Corporation
    • Fette Compacting
    • LEISTRITZ AG
    • KORSCH AG
    • ACG
    • Cadmach Machinery Co. Pvt 。有限公司
    • ALEXANDERWERK AG
    • Hovione
    Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    Frequently Asked Questions


    What is pharmaceutical continuous manufacturing?

    Continuous Manufacturing technology is a method in which continuous development of products is involved to allow faster manufacturing with more productive and profitable products. The continuous manufacturing method in the pharmaceutical attributes to the production of an active component in a compressed unit with a high degree of automation. The market is driven by less time investment, less production cost, faster availability of reliable products in the market.

    What are the driving factors for the pharmaceutical continuous manufacturing marketacross the globe?

    The growth of the market is attributed to some key driving factors such as increasing shortage of medicines, and advantages offered by continuous manufacturing process. However, high capital costs required for the establishment of these systems expected to restraint the growth of the market during the forecast years.

    What is the regional analysis in terms of pharmaceutical continuous manufacturing market?

    Global pharmaceutical continuous manufacturing market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. In North America, the U.S. is the largest market for pharmaceutical continuous manufacturing. The federal government in the US and regulatory authorities are supportive towards transition from batch to continuous manufacturing of drugs and APIs which is leading to increasing number of companies and contract manufacturers adopting the techniques thereby leading to the market growth.The Asia Pacific region is expected to account for the fastest growth in the pharmaceutical continuous manufacturing market. In Japan and South Korea, the market is expected to grow owing to factors such as the large population countries such as China and India, increasing focus of market players towards Asian countries to open new production facilities in these regions, rising number of pharmaceutical companies.

    The List of Companies - Pharmaceutical Continuous Manufacturing Market

    1. GEA Group
    2. Coperion GmbH
    3. Gericke AG
    4. Glatt GmbH
    5. Hosokawa Micron Group
    6. Munson Machinery Co. Inc.
    7. Powrex Corp
    8. Thermo Fisher Scientific Inc.
    9. Freund-vector Corporation
    10. Fette Compacting
    11. Alexanderwerk
    12. LEISTRITZ AG
    13. KORSCH AG
    14. ACG
    15. Cadmach Machinery Co. Pvt. Ltd.
    16. Hovioneen Aesica

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Related Reports